| Title | Effectiveness of Simeprevir plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection. |
| Publication Type | Journal Article |
| Year of Publication | 2015 |
| Authors | Sulkowski, M. S., H. E. Vargas, A. M. Di Bisceglie, P. A. Kuo, K. R. Reddy, J. K. Lim, G. Morelli, J. M. Darling, J. J. Feld, R. S. Brown, L. M. Frazier, T. G. Stewart, M. W. Fried, D. R. Nelson, and I. M. Jacobson |
| Corporate Authors | HCV-TARGET study group |
| Journal | Gastroenterology |
| Date Published | 2015 Oct 21 |
| ISSN | 1528-0012 |
| Abstract | The interferon-free regimen of simeprevir plus sofosbuvir was recommended by professional guidelines for certain patients with hepatitis C virus (HCV) genotype 1 infection based on the findings of a phase 2 trial. We aimed to evaluate the safety and efficacy of this regimen in clinical practice settings in North America. |
| DOI | 10.1053/j.gastro.2015.10.013 |
| Alternate Journal | Gastroenterology |
